These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 8155839)

  • 21. Molecular and phenotypic characterization of potentially new Shigella dysenteriae serotype.
    Coimbra RS; Lenormand P; Grimont F; Bouvet P; Matsushita S; Grimont PA
    J Clin Microbiol; 2001 Feb; 39(2):618-21. PubMed ID: 11158117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differentiation of Shiga toxin and Vero cytotoxin type 1 genes by polymerase chain reaction.
    Pollard DR; Johnson WM; Lior H; Tyler SD; Rozee KR
    J Infect Dis; 1990 Nov; 162(5):1195-8. PubMed ID: 2230244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Production and characterization of monoclonal antibodies with therapeutic potential against Shiga toxin.
    Islam MS; Stimson WH
    J Clin Lab Immunol; 1990 Sep; 33(1):11-6. PubMed ID: 1966939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variation in the Shiga toxin region of 20th-century epidemic and endemic Shigella dysenteriae 1 strains.
    Greco KM; McDonough MA; Butterton JR
    J Infect Dis; 2004 Jul; 190(2):330-4. PubMed ID: 15216469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nucleotide sequence of the Shiga-like toxin genes of Escherichia coli.
    Calderwood SB; Auclair F; Donohue-Rolfe A; Keusch GT; Mekalanos JJ
    Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4364-8. PubMed ID: 3299365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of Shigella dysenteriae serotypes 11, 12, and 13.
    Wathen-Grady HG; Britt LE; Strockbine NA; Wachsmuth IK
    J Clin Microbiol; 1990 Nov; 28(11):2580-4. PubMed ID: 1701447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minimum domain of the Shiga toxin A subunit required for enzymatic activity.
    Haddad JE; al-Jaufy AY; Jackson MP
    J Bacteriol; 1993 Aug; 175(16):4970-8. PubMed ID: 8349540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expression of GST-3B fusion protein of Escherichia coli of Ee strain producing SLT-IIe toxin and study on its biological activities and immunogenicity].
    Liu GP; Wu B; Lin YY; Jin ML; Chen HC
    Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):686-91. PubMed ID: 17944373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-O157:H7 pathogenic Shiga toxin-producing Escherichia coli: phenotypic and genetic profiling of virulence traits and evidence for clonality.
    Schmidt H; Geitz C; Tarr PI; Frosch M; Karch H
    J Infect Dis; 1999 Jan; 179(1):115-23. PubMed ID: 9841830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of prokaryotic translation by the Shiga toxin enzymatic subunit.
    Skinner LM; Jackson MP
    Microb Pathog; 1998 Feb; 24(2):117-22. PubMed ID: 9480794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A monoclonal antibody to Shigella dysenteriae serotype 13 cross-reacting with Shiga toxin.
    Qadri F; Azim T; Hossain A; Islam D; Mondal G; Faruque SM; Albert MJ
    Adv Exp Med Biol; 1995; 371B():923-6. PubMed ID: 7502927
    [No Abstract]   [Full Text] [Related]  

  • 32. Molecular cloning of Clostridium perfringens epsilon-toxin gene and its high level expression in E. coli.
    Goswami PP; Rupa P; Prihar NS; Garg LC
    Biochem Biophys Res Commun; 1996 Sep; 226(3):735-40. PubMed ID: 8831683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of Shiga toxin-producing Shigella dysenteriae type 1 and Escherichia coli by using polymerase chain reaction with incorporation of digoxigenin-11-dUTP.
    Jackson MP
    J Clin Microbiol; 1991 Sep; 29(9):1910-4. PubMed ID: 1774316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Escherichia coli Shiga toxin.
    Nakao H; Takeda T
    J Nat Toxins; 2000 Aug; 9(3):299-313. PubMed ID: 10994531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of DNA probes for cytotoxin and enterotoxin genes in enteric bacteria.
    Brazil GM; Clayton CL; Sekizaki T; Timmis KN
    Experientia; 1988 Oct; 44(10):848-53. PubMed ID: 3053231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human microvascular endothelial cells are strongly sensitive to Shiga toxins.
    Ohmi K; Kiyokawa N; Takeda T; Fujimoto J
    Biochem Biophys Res Commun; 1998 Oct; 251(1):137-41. PubMed ID: 9790920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical Characterization of In vitro Reconstituted Biologically Active Recombinant Shiga Toxin.
    Chauhan V; Chauhan R; Sonkar P; Dhaked RK
    Protein Pept Lett; 2019; 26(3):227-234. PubMed ID: 30592251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Production of Shiga toxin and other cytotoxins by serogroups of Shigella.
    Bartlett AV; Prado D; Cleary TG; Pickering LK
    J Infect Dis; 1986 Dec; 154(6):996-1002. PubMed ID: 3537154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthetic peptides of Shiga toxin B-subunit induce antibodies which neutralize the biological activities of the toxin.
    Harari I; Donohue-Rolfe A; Keusch GT; Arnon R
    Ann Sclavo Collana Monogr; 1986; 3(1-2):125-30. PubMed ID: 3322336
    [No Abstract]   [Full Text] [Related]  

  • 40. Heterogeneity of Shiga toxin-producing Escherichia coli strains isolated from hemolytic-uremic syndrome patients, cattle, and food samples in central France.
    Pradel N; Boukhors K; Bertin Y; Forestier C; Martin C; Livrelli V
    Appl Environ Microbiol; 2001 Jun; 67(6):2460-8. PubMed ID: 11375151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.